DWS Investments dws.com

DWS Investments - Investments & Acquisitions

Show Real Data DWS Investments Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-11-05Neo TechnologiesCorporate Minority
2007-10-19Optimer PharmaceuticalsPIPE$35.88MBaker Brothers Investments, Balyasny Asset Management, CIDC, Deerfield Management, Enable Capital Management, HBK Investments, Iroquois Capital Group, Mediphase Venture Partners, Perceptive Advisors, President International Development, Prudence Venture Investment Corporation, Tang Capital Management, UBS, and Visium Asset Management
2006-03-17ZalicusPIPE$48MAbingworth, American International Group, AWM Investment Company, Balyasny Asset Management, Bass Companies, Clariden Leu, Domain Associates, Fort Mason Capital, Integral Capital Partners, Kamunting Street Capital Management, Millennium Management, ProMed Capital, QVT Financial, SF Capital Group, Soros Fund Management, Steeple Capital, T. Rowe Price, TD Asset Management, TD Capital, TowerBrook Capital Partners, UBS, and Visium Asset Management
2005-09-20Delta PetroleumUnattributed VC$100MAfton Capital Management, Atoll Asset Management, Bass Companies, Calm Waters Partnership, Copper Beech Capital Management, Cormark Securities, Dreman Value Management, GLG Partners, Highside Capital Management, JVL Advisors, Knoll Capital Management, KOM Capital Management, Peninsula Capital Management, Ridgecrest Investment Management, Royal Trust Corporation Of Canada, SDS Capital Partners, and Touradji Capital Management
2004-05-05BioenvisionUnattributed VC - II$16.27MAisling Capital, Alexandra Investment Management, Alpha Capital Partners, Balyasny Asset Management, BayStar Capital, BioPharmaceutical Portfolio, Deutsche Asset Management, Deutsche Bank, DKR Capital, Downsview Capital, Hudson Bay Capital Management, Iroquois Capital Group, Jennison Associates, Meditor Capital Management, Mehta Partners, Merlin Biomed Group, Millennium Partners, North Sound Capital, OrbiMed Advisors, Perceptive Advisors, Perseus, Quogue Capital, Scudder Global Biotechnology Fund, SDS Capital Partners, SF Capital Group, Stonestreet, UBS, and Vertical Ventures
See all 20 investments